NIH-funded research R21 grant

Understanding how sperm survive in the oviduct despite immune responses

Official title: Oviduct Siglecs: Role in the Sperm Immune Response

Funded at University of Illinois at Urbana-Champaign · NIH-10997422 · Data updated 2026-11-12

This study is looking at how sperm can safely hang out in the oviduct without being attacked by the immune system, which is important for helping them reach the egg for fertilization.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Illinois at Urbana-Champaign
NIH-funded
Lab location1 site (Champaign, United States)
Project startDecember 8, 2023
Project endNovember 30, 2025
Funding year2025
Award (this year)$178,212
NIH project number5R21HD111954-02
Project IDNIH-10997422 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals experiencing infertility or difficulties in conception.

Less likely to help

Patients who are not trying to conceive or have no fertility issues may not benefit from this research.

What this research studies

This research investigates the unique ability of sperm to survive in the oviduct, where they are not attacked by the immune system, unlike in the uterus. The study focuses on the interactions between sperm and uterine cells, particularly how sperm can evade phagocytosis by immune cells. By examining the role of specific molecules called Siglecs and the sialic acid-terminating glycans on sperm, the research aims to uncover the mechanisms that allow sperm to persist in the oviduct for extended periods, which is crucial for successful fertilization.

Why it matters

Potential benefit: If successful, this research could lead to new insights into fertility and potential treatments for individuals facing challenges in achieving pregnancy.

How similar studies have gone: While the specific mechanisms of sperm survival in the oviduct are not fully understood, similar research has shown promise in understanding immune interactions in reproductive biology.

Where this research is happening

  • University of Illinois at Urbana-Champaign
    Champaign, United States
    Active

Researchers

  • Principal investigator: Miller, David Joel — University of Illinois at Urbana-Champaign
  • Study coordinator: Miller, David Joel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.